OpenVSafe by OpenVAERS
Search V-safe

XWK-17689-13397

2 vaccinations 13 coded responses 23 check-ins 13 free-text entries 1 call case
Sex
Female
Age at first dose
56-60
ZIP prefix
520 / IA
Registered
2021-03-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-04
    Registered in v-safe
  3. 2021-03-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  4. 2021-03-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Pyrexia — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  5. 2021-03-06
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  6. 2021-03-07
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  7. 2021-03-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  8. 2021-03-10
    Health check-in — 7 day, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-19
    Survey response — 14 day, dose 1
    MedDRA: Injection site pruritus — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  10. 2021-03-24
    Dose 2 — Pfizer-BioNTech
  11. 2021-03-24
    Survey response — 0 day, dose 2
    MedDRA: Dizziness, Hyperhidrosis — Feeling: Fair · Site: Pain, Redness · Fever · Headache, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  12. 2021-03-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Pain in extremity — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  13. 2021-03-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  14. 2021-03-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  15. 2021-03-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Rash — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  16. 2021-03-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  17. 2021-03-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pruritus, Rash — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  18. 2021-03-31
    Health check-in — 7 day, dose 2
    Feeling: Good · Site: Pain, Redness, Itching · None
    Adult check-in
  19. 2021-04-07
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-14
    Health check-in — 21 day, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-21
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-28
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-05
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-23
    Health check-in — 3 month, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-09-22
    Health check-in — 6 month, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-03-26
    Survey response — 12 month, dose 2
    MedDRA: Diabetes mellitus — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11 · check-in answers available
  27. 2022-03-26
    Report sent to call center — 12 month, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2022-03-29

Vaccinations

DoseDateManufacturerCo-administered
12021-03-03Pfizer-BioNTech
22021-03-24Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-03-26 Unsuccessful

Free text

Release 5

Systemic reaction (other): Dizzy/lightheaded

Systemic reaction (other): Fever, lightheaded

Systemic reaction (other): Swollen lymph nodes in neck & armpit area.

Systemic reaction (other): Swollen lymph nodes in neck & armpit area

Systemic reaction (other): Still have swollen lymph nodes in neck & armpit area.

Symptoms: Itching at injection site.

Release 6

Systemic reaction (other): Lightheaded & dizzy. Sweaty.

Systemic reaction (other): Swollen lymph nodes in neck, very sore arm.

Systemic reaction (other): Swollen lymph nodes.

Systemic reaction (other): Swollen lymph nodes in neck & armpit area.

Systemic reaction (other): Rash on arm of injection. Swollen lymph nodes in neck & armpit.

Systemic reaction (other): Rash on arm that I got the injection & itching.

Release 11

Symptoms: Diabetes

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDiabetes mellitus · · ✓
SDInjection site pruritus ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓
SROPruritus ✓ ✓ ✓
SROPyrexia ✓ ✓ ✓
SRORash ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release